We are creating a future where humanity and the planet can thrive

We are a venture creator, combining available scientific knowledge and founder-type scientists into high-impact ventures

Create with us

We focus on 4 sectors:

Agriculture
Computation
Climate
Pharma

Restorative Cultivation

Creating ventures to transition agriculture from extractive to regenerative practices
Learn more

Scaling intelligence

Creating ventures that unlock the potential of computational leverage
Learn more

Reversing global heating

Creating ventures that optimise for degrees of global heating averted
Learn more

Curative Therapeutics

Creating ventures to cure diseases, using emerging combinatorial techniques
Learn more
01 / 04
Companies launched
35
Outcomes in development
40+
Active Community
472
members
Funding Attracted
£100m

How we do it

01
Deep expertise and partnerships with industry leaders
02
The best founders and a proven methodology
03
De-risked ventures and world-class investors
How we create ventures

Create with us

Are you interested in helping us build a thriving future for humanity and the planet?
We are always open to meeting new partners, founders and investors.
Contact us

Content

Featured articles

Creating a Thriving Future
28 July 2022

Why agriculture venture-building should focus on bioregions
25 July 2022

Unlocking a post-Moore's Law approach to computing
29 July 2022

Outcomes Graph: A protocol for applied science coordination
28 September 2022

We need to make atoms-based entrepreneurship cool again
06 March 2023

Recent articles
  • agriculture
  • Bioeconomy

Unlocking the Potential of Agricultural Residues

Agricultural residues are increasingly no longer seen as waste, but as valuable resources and inputs for other sectors of the economy. While advancements in technology are enabling the transformation of these raw materials into products, we are still failing to harness these resources effectively, with vast amounts of potential feedstocks being wasted or used for low-value applications. In this article, we explore how a commodity market for these materials might help us overcome this problem.

27 September 2023
  • pharmaceuticals
  • Neurofibromatosis

Gene Therapy for Neurofibromatosis - the Path to a Cure

Despite being among the most common genetic disorders worldwide (1 in ~2500 births collectively) the NF field has sadly been overlooked for decades. Yet it is difficult to understand why, given the huge unmet need and extremely limited treatment options – none of which offer curative potential for patients. Gene therapy offers the path towards a cure. In this article, we outline the nature of the challenge, why now is the right time to solve it, and explore the unanswered questions we'd like to address through venture creation. 

08 August 2023
View all posts